pSivida sells AION Diagnostics for $3.6m Perth-headquartered bio-nanotech company pSivida Ltd has sold its subsidiary AION Diagnostics Inc to US-based private equity group GEM Global Yield Fund for around $3.6 million, following the company's float on the Frankfurt Stock Exchange. 13 Apr 2007
